Seminars in Immunopathology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 11.5 | Q1 | 98.9% | 3.412 | Q1 | 98.1% |
| 2024 | 9.2 | Q1 | 96.7% | 2.945 | Q1 | 97.6% |
| 2023 | 7.9 | Q1 | 96.2% | 2.695 | Q1 | 97.3% |
| 2022 | 9.0 | Q1 | 97.4% | 2.462 | Q1 | 97.0% |
| 2021 | 11.8 | Q1 | 97.4% | 2.423 | Q1 | 97.1% |
| 2020 | — | — | 4.778 | Q1 | 99.0% | |
| 2019 | — | — | 2.920 | Q1 | 97.7% | |
| 2018 | — | — | 2.691 | Q1 | 97.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1863-2300
ISSN
1863-2297
country
DEcoverage
2007-2025